← Open Payments lookup

AMBER VIEL: Open Payments

NPI 1083987317 · WHITE MARSH, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,387 in 64 payments from 15 companies in 2025. Trend: 2023 $1,408 · 2024 $1,591 · 2025 $1,387

Food & beverage: $1,387
CompanyPaymentsAmount
GlaxoSmithKline, LLC.14$287
AstraZeneca Pharmaceuticals LP9$230
Regeneron Healthcare Solutions, Inc.10$198
Genentech USA, Inc.6$138
Novartis Pharmaceuticals Corporation5$119
GENZYME CORPORATION5$101
Amgen Inc.4$80
ABBVIE INC.2$53
ARS Pharmaceuticals Operations, Inc.2$41
Organon LLC2$29

Products named: DUPIXENT, FASENRA, NUCALA, Xolair, TRELEGY ELLIPTA, TEZSPIRE, RINVOQ, Rhapsido.

Industry payments across MD — which companies pay providers there.